Xeris Biopharma Holdings, Inc. (XERS)
5.51
+0.21
(+3.96%)
USD |
NASDAQ |
Mar 26, 12:28
Xeris Biopharma Holdings Free Cash Flow : 27.93M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Corcept Therapeutics, Inc. | 141.78M |
| Zoetis, Inc. | 2.283B |
| Harrow, Inc. | 42.76M |
| Zymeworks, Inc. | -35.43M |
| Vir Biotechnology, Inc. | -396.61M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 20.04M |
| Cash from Investing (Quarterly) | -0.333M |
| Cash from Financing (Quarterly) | -0.266M |
| Free Cash Flow Per Share (Quarterly) | 0.1095 |
| Free Cash Flow to Equity (Quarterly) | 19.27M |
| Free Cash Flow to Firm (Quarterly) | 26.86M |
| Free Cash Flow Yield | 3.03% |